Stratasys Reports Third Quarter 2020 Financial Results

Rhea-AI Summary

Stratasys Ltd. (NASDAQ: SSYS) reported its Q3 2020 financial results, revealing a revenue drop of 18.8% to $127.9 million compared to $157.5 million last year, largely due to COVID-19 impacts. GAAP gross margin decreased to 38.9% from 49.2%, while non-GAAP gross margin fell to 46.8% from 52.4%. The company recorded a significant GAAP operating loss of $404.3 million, largely attributed to a non-cash goodwill impairment charge of $386.2 million. Despite these challenges, Stratasys generated $2.6 million in cash from operations and ended the quarter with $308.2 million in cash, maintaining no debt.

Positive

• Sequential improvement in gross margins, with GAAP and non-GAAP margins up by 170bp and 140bp from Q2.
• Generated $2.6 million in cash from operations during Q3.
• Ended Q3 with $308.2 million in cash, cash equivalents, and short-term deposits.

Negative

• Revenue decreased by 18.8% compared to Q3 2019.
• GAAP operating loss increased to $404.3 million from a loss of $6.0 million in Q3 2019.
• Non-cash goodwill impairment charge of $386.2 million impacting net loss.

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the third quarter of 2020.

Q3 2020 Financial Results Summary:

• Revenue for the third quarter of 2020 was $127.9 million, compared to $157.5 million for the same period last year. The 18.8% reduction was primarily driven by the adverse impact of COVID-19 on the company’s customers throughout the industries into which the company sells its products and services.
• GAAP gross margin was 38.9% for the quarter, compared to 49.2% for the same period last year. Non-GAAP gross margin was 46.8% for the quarter, compared to 52.4% for the same period last year. GAAP and non-GAAP gross margin improved sequentially from Q2 by 170bp and 140bp, respectively. The company believes that gross margins will continue to recover as and when our customers return to their pre-COVID utilization levels.
• GAAP operating loss for the quarter was $404.3 million, compared to GAAP operating loss of $6.0 million for the same period last year, mainly due to the non-cash goodwill impairment charge of $386.2 million. Non-GAAP operating loss for the quarter was $1.0 million, compared to non-GAAP operating income of $8.1 million for the same period last year.
• GAAP net loss for the quarter was $405.1 million, or ($7.35) per diluted share, compared to GAAP net loss of $6.9 million, or ($0.13) per diluted share, for the same period last year, mainly due to the non-cash goodwill impairment charge of $386.2 million. Non-GAAP net loss for the quarter was $3.0 million, or ($0.05) per diluted share, compared to non-GAAP net income of $6.3 million, or $0.12 per diluted share, for the same period last year.
• Non-GAAP EBITDA was $5.2 million for the quarter, compared to $14.5 million for the same period last year. Non-GAAP EBITDA improved sequentially from Q2 by $6.8 million.
• The Company recorded a non-cash goodwill impairment charge of $386.2 million, or $7.01 per share, related to the Company’s FDM and PolyJet technologies, primarily as a result of the COVID-19 impact on the Company’s business.
• The Company generated $2.6 million of cash from operations and ended the period with $308.2 million in cash, cash equivalents and short-term deposits. The Company has no debt.

“We were pleased to see sequential improvements in both our top and bottom lines for this quarter, reflecting the beginning of a potential recovery from the pandemic,” said Yoav Zeif, CEO of Stratasys. “We are laser-focused on leading the polymer 3D printing market by delivering the most innovative, next-gen technologies to address the fastest-growing and most transformative manufacturing applications, while leveraging the strongest go-to-market infrastructure in our industry. We believe that our innovations of today will drive competitive production advantages for the factories of tomorrow, resulting in growth and value creation for our customers and shareholders.”

Stratasys Ltd. Q3 2020 Conference Call Details

The Company plans to hold the conference call to discuss its third quarter 2020 financial results on Thursday, November 12, 2020 at 8:30 a.m. (ET).

The investor conference call will be available via live webcast on the Stratasys Website at investors.stratasys.com, or directly at the following web address: https://78449.themediaframe.com/dataconf/productusers/ssys/mediaframe/41658/indexl.html

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for 6 months at investors.stratasys.com, or by accessing the above-provided web address.

Stratasys (Nasdaq: SSYS) is a global leader in additive manufacturing or 3D printing technology and is the manufacturer of FDM^®, PolyJet™, and stereolithography 3D printers. The company’s technologies are used to create prototypes, manufacturing tools, and production parts for industries, including aerospace, automotive, healthcare, consumer products and education. For more than 30 years, Stratasys products have helped manufacturers reduce product-development time, cost, and time-to-market, as well as reduce or eliminate tooling costs and improve product quality. The Stratasys 3D printing ecosystem of solutions and expertise includes 3D printers, materials, software, expert services, and on-demand parts production.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the duration of the global COVID-19 pandemic, which, if extending for a further significant period of time, may continue to impact, in a material adverse manner, our operations, financial position and cash flows, and those of our customers and suppliers; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower-margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating acquisitions or investments in new businesses, technologies, products or services; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our operations, supply chain, liquidity, cash flow and customer orders); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2019 (the “2019 Annual Report”), which we filed with the Securities and Exchange Commission (the “SEC”) on February 26, 2020. Readers are urged to carefully review and consider the various disclosures made throughout our 2019 Annual Report and the Report of Foreign Private Issuer on Form 6-K that attaches Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly period ended September 30, 2020, which we are furnishing to the SEC on or about the date hereof, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are made as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of non-GAAP financial measures

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our Company in gauging our results of operations on an ongoing basis after (i) excluding mergers, acquisitions and divestments related expense or gains and restructuring-related charges or gains, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of goodwill and long-lived assets, and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

Stratasys Ltd.
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)
		September 30,				December 31,
		2020				2019
ASSETS
Current assets
Cash and cash equivalents		$	252,906			$	293,484
Short-term deposits		$	55,300			$	28,300
Accounts receivable, net			103,693				132,558
Inventories			152,685				168,504
Prepaid expenses			7,568				6,567
Other current assets			19,209				29,659
Total current assets			591,361				659,072
Non-current assets
Property, plant and equipment, net			198,521				189,706
Goodwill			-				385,658
Other intangible assets, net			65,083				87,328
Operating lease right-of-use assets			18,905				20,936
Other non-current assets			35,238				38,819
Total non-current assets			317,747				722,447
Total assets		$	909,108			$	1,381,519
LIABILITIES AND EQUITY
Current liabilities
Accounts payable		$	23,478			$	35,818
Accrued expenses and other current liabilities			26,462				28,528
Accrued compensation and related benefits			28,536				34,013
Deferred revenues			47,288				52,268
Operating lease liabilities - short term			8,675				9,292
Total current liabilities			134,439				159,919
Non-current liabilities
Deferred revenues - long-term			13,436				16,039
Operating lease liabilities - long term			10,600				12,445
Other non-current liabilities			33,291				35,343
Total non-current liabilities			57,327				63,827
Total liabilities			191,766				223,746
Redeemable non-controlling interests			568				622
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 55,112 thousands shares and 54,441 thousands shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively			150				148
Additional paid-in capital			2,722,839				2,706,894
Accumulated other comprehensive loss			(9,289	)			(7,716	)
Accumulated deficit			(1,996,926	)			(1,542,175	)
Total equity			716,774				1,157,151
Total liabilities and equity		$	909,108			$	1,381,519

Stratasys Ltd.
Consolidated Statements of Operations
(in thousands, except per share data)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2020				2019				2020				2019
		(unaudited)				(unaudited)				(unaudited)				(unaudited)
Net sales
Products		$	83,548			$	106,346			$	240,597			$	321,778
Services			44,344				51,114				137,825				154,145
			127,892				157,460				378,422				475,923
Cost of sales
Products			47,339				44,341				126,556				135,605
Services			30,784				35,710				98,491				105,285
			78,123				80,051				225,047				240,890
Gross profit			49,769				77,409				153,375				235,033
Operating expenses
Research and development, net			19,562				23,620				65,059				70,234
Selling, general and administrative			48,343				59,741				155,630				173,217
Goodwill impairment			386,154				-				386,154				-
			454,059				83,361				606,843				243,451
Operating loss			(404,290	)			(5,952	)			(453,468	)			(8,418	)
Financial income (expense), net			(167	)			289				(847	)			2,796
Loss before income taxes			(404,457	)			(5,663	)			(454,315	)			(5,622	)
Income tax expenses (benefit)			(343	)			586				(2,250	)			3,084
Share in profits (losses) of associated companies			(952	)			(733	)			(2,740	)			495
Net Loss			(405,066	)			(6,982	)			(454,805	)			(8,211	)
Net loss attributable to non-controlling interests			(4	)			(41	)			(54	)			(152	)
Net loss attributable to Stratasys Ltd.		$	(405,062	)		$	(6,941	)		$	(454,751	)		$	(8,059	)
Net loss per ordinary share attributable to Stratasys Ltd.
Basic		$	(7.35	)		$	(0.13	)		$	(8.29	)		$	(0.15	)
Diluted		$	(7.35	)		$	(0.13	)		$	(8.29	)		$	(0.15	)
Basic			55,086				54,394				54,851				54,201
Diluted			55,086				54,394				54,851				54,201

				Three Months Ended September 30,
				2020				Non-GAAP				2020				2019				Non-GAAP				2019
				GAAP				Adjustments				Non-GAAP				GAAP				Adjustments				Non-GAAP
				U.S. dollars and shares in thousands (except per share amounts)
		Gross profit (1)		$	49,769			$	10,036			$	59,805			$	77,409			$	5,087			$	82,496
		Operating income (loss) (1,2)			(404,290	)			403,268				(1,022	)			(5,952	)			14,055				8,103
		Net income (loss) attributable to Stratasys Ltd. (1,2,3)			(405,062	)			402,050				(3,012	)			(6,941	)			13,275				6,334
		Net income (loss) per diluted share attributable to Stratasys Ltd. (4)		$	(7.35	)		$	7.30			$	(0.05	)		$	(0.13	)		$	0.25			$	0.12
(1)		Acquired intangible assets amortization expense							4,065												3,916
		Non-cash stock-based compensation expense							524												475
		Restructuring and other related costs							191												696
		Impairment charges of intangible assets							5,256												-
									10,036												5,087
(2)		Acquired intangible assets amortization expense							2,162												2,016
		Non-cash stock-based compensation expense							4,352												4,960
		Goodwill impairment							386,154												-
		Restructuring and other related costs							34												1,992
		Other expenses							530												-
									393,232												8,968
									403,268												14,055
(3)		Corresponding tax effect							(1,296	)											(780	)
		Equity method related amortization, divestments and impairments							78												-
								$	402,050											$	13,275
(4)		Weighted average number of ordinary shares outstanding- Diluted			55,086								55,086				54,394								54,940

				Nine Months Ended September 30,
				2020				Non-GAAP				2020				2019				Non-GAAP				2019
				GAAP				Adjustments				Non-GAAP				GAAP				Adjustments				Non-GAAP
				U.S. dollars and shares in thousands (except per share amounts)
		Gross profit (1)		$	153,375			$	24,062			$	177,437			$	235,033			$	13,780			$	248,813
		Operating income (loss) (1,2)			(453,468	)			435,987				(17,481	)			(8,418	)			32,376				23,958
		Net income (loss) attributable to Stratasys Ltd. (1,2,3)			(454,751	)			433,821				(20,930	)			(8,059	)			28,574				20,515
		Net income (loss) per diluted share attributable to Stratasys Ltd. (4)		$	(8.29	)		$	7.91			$	(0.38	)		$	(0.15	)		$	0.53			$	0.38
(1)		Acquired intangible assets amortization expense							12,196												11,714
		Non-cash stock-based compensation expense							1,424												1,370
		Restructuring and other related costs							5,187												696
		Impairment charges of intangible assets							5,256												-
									24,062												13,780
(2)		Acquired intangible assets amortization expense							6,430												5,688
		Non-cash stock-based compensation expense							14,470												14,387
		Goodwill impairment							386,154												-
		Restructuring and other related costs							3,863												(1,479	)
		Other expenses							1,007												-
									411,925												18,596
									435,987												32,376
(3)		Corresponding tax effect							(2,396	)											(2,198	)
		Equity method related amortization, divestments and impairments							230												(1,604	)
								$	433,821											$	28,574
(4)		Weighted average number of ordinary shares outstanding- Diluted			54,851								54,851				54,201								54,705